Skip to main content

Washington, D.C. – House Majority Leader Kevin McCarthy (CA-23) released the following statement on House passage of S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act:

“Zika is a growing risk, and we must take action to stop its growth and find a cure. This bill adds Zika to a priority review voucher program at the Food and Drug Administration (FDA), creating a major incentive for companies to develop medicines and vaccines to treat and prevent this disease. By adding Zika to this program, we encourage innovators to develop an effective treatment for this latest public health crisis.”